The METOCARD-CNIC ( Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction ) trial recruited @ patients with Killip class II anterior STEMI presenting early after symptom onset ( < @ h ) and randomized them to pre-reperfusion IV metoprolol or control group .